A popular weight loss drug may be able to assist in the treatment of sleep apnea, a new study found. Tirzepatide, the medicine found in the drug Zepbound and the obesity drug Mounjaro, reduced the … ...

June 21 (UPI) --Treating obstructive sleep apnea with a type 2 diabetes medication may offer new hope for sufferers of the sleep disorder, a new study released Friday indicates. Researchers at ...

Zepbound was approved last year to treat obesity. The drug's maker, Eli Lilly, says it reduces the severity of obstructive sleep apnea by 63%.

A late-stage trial of Eli Lilly’s weight loss drug Zepbound showed promising results in treating sleep apnea symptoms in obese adults, the company announced Wednesday, the latest findings ...

A popular weight loss drug may be able to assist in the treatment of sleep apnea, a new study found. Tirzepatide, the medicine found in the drug Zepbound and the obesity drug Mounjaro, reduced the ...

Zepbound was approved last year to treat obesity. The drug's maker, Eli Lilly, says it reduces the severity of obstructive sleep apnea by 63%.